scholarly article | Q13442814 |
P50 | author | David Smith | Q59681685 |
P2093 | author name string | Robert J Goldstone | |
P2860 | cites work | Antibiotic resistance is prevalent in an isolated cave microbiome | Q21089884 |
Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis | Q24201201 | ||
MUSCLE: multiple sequence alignment with high accuracy and high throughput | Q24613456 | ||
The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections | Q24623245 | ||
Multidrug efflux pumps of gram-negative bacteria | Q24681708 | ||
Basic local alignment search tool | Q25938991 | ||
Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis | Q26783911 | ||
Crystal structure of bacterial multidrug efflux transporter AcrB | Q27639761 | ||
RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models | Q27860746 | ||
Environmental microbiology: plant bacteria thrive in storm clouds | Q86122523 | ||
Selection of conserved blocks from multiple alignments for their use in phylogenetic analysis | Q27860925 | ||
Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe | Q28477449 | ||
APE: Analyses of Phylogenetics and Evolution in R language | Q29546513 | ||
Origins and evolution of antibiotic resistance | Q29617791 | ||
Genomic content typifying a prevalent clade of bovine mastitis-associated Escherichia coli. | Q30378240 | ||
Relationship of protein structure of isoleucyl-tRNA synthetase with pseudomonic acid resistance of Escherichia coli. A proposed mode of action of pseudomonic acid as an inhibitor of isoleucyl-tRNA synthetase | Q30419839 | ||
Key role of Mfd in the development of fluoroquinolone resistance in Campylobacter jejuni | Q33340967 | ||
Multiple antibiotic resistance and efflux | Q33538677 | ||
Patterns of antimicrobial resistance observed in Escherichia coli isolates obtained from domestic- and wild-animal fecal samples, human septage, and surface water | Q33716505 | ||
Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment | Q33722082 | ||
Resistance to trimethoprim-sulfamethoxazole | Q33945728 | ||
Prevalence, antibiotic susceptibility, and diversity of Escherichia coli O157:H7 isolates from a longitudinal study of beef cattle feedlots | Q33989285 | ||
Multidrug resistance mechanisms: drug efflux across two membranes | Q33994542 | ||
Antimicrobial use and resistance in animals | Q34126636 | ||
AcrAB and related multidrug efflux pumps of Escherichia coli. | Q34231114 | ||
In vitro activity of fosfomycin against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures. | Q34301565 | ||
PatA and PatB form a functional heterodimeric ABC multidrug efflux transporter responsible for the resistance of Streptococcus pneumoniae to fluoroquinolones | Q34403792 | ||
Genetic diversity and antimicrobial resistance among isolates of Escherichia coli O157: H7 from feces and hides of super-shedders and low-shedding pen-mates in two commercial beef feedlots | Q34422040 | ||
Temporal trends and risk factors for extended-spectrum beta-lactamase-producing Escherichia coli in adults with catheter-associated urinary tract infections | Q34459919 | ||
Intracellular accumulation of linezolid in Escherichia coli, Citrobacter freundii and Enterobacter aerogenes: role of enhanced efflux pump activity and inactivation | Q34565936 | ||
Evolution of Escherichia coli rifampicin resistance in an antibiotic-free environment during thermal stress | Q34596522 | ||
Typical and atypical enteropathogenic Escherichia coli | Q34628717 | ||
Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study | Q34686057 | ||
A new sulfonamide resistance gene (sul3) in Escherichia coli is widespread in the pig population of Switzerland | Q34734839 | ||
Antimicrobial co-resistance patterns of gram-negative bacilli isolated from bloodstream infections: a longitudinal epidemiological study from 2002-2011. | Q34875817 | ||
Antimicrobial activities of 81.723 hfu, a new pleuromutilin derivative | Q34926918 | ||
Effects of elfamycins on elongation factor Tu from Escherichia coli and Staphylococcus aureus | Q35244851 | ||
Antibiotic resistance mutations in 16S and 23S ribosomal RNA genes ofEscherichia coli | Q35284526 | ||
Multidrug efflux pumps and resistance: regulation and evolution | Q35565587 | ||
Plasmid-mediated high-level resistance to erythromycin in Escherichia coli | Q35649028 | ||
The microbiome of uncontacted Amerindians | Q35897279 | ||
Antimicrobial drug resistance in Escherichia coli from humans and food animals, United States, 1950-2002. | Q35979592 | ||
Multidrug-resistance efflux pumps - not just for resistance | Q36538111 | ||
Prevalence of antibiotic resistance in Escherichia coli: overview of geographical, temporal, and methodological variations | Q36712272 | ||
Antimicrobial resistance: a global response | Q36937884 | ||
The comprehensive antibiotic resistance database. | Q36969864 | ||
Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period | Q37072043 | ||
Antimicrobial resistance in Escherichia coli isolates from swine and wild small mammals in the proximity of swine farms and in natural environments in Ontario, Canada | Q37075650 | ||
A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study | Q37766420 | ||
Antimicrobial resistance 1979-2009 at Karolinska hospital, Sweden: normalized resistance interpretation during a 30-year follow-up on Staphylococcus aureus and Escherichia coli resistance development | Q37780780 | ||
Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000-2009. | Q38126815 | ||
Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes | Q39476891 | ||
AcrD of Escherichia coli is an aminoglycoside efflux pump | Q39499577 | ||
Development of a whole-cell assay for peptidoglycan biosynthesis inhibitors | Q39651496 | ||
The putative response regulator BaeR stimulates multidrug resistance of Escherichia coli via a novel multidrug exporter system, MdtABC | Q39679800 | ||
HGT-DB: a database of putative horizontally transferred genes in prokaryotic complete genomes | Q39790145 | ||
gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli | Q39814986 | ||
Mechanisms of antibiotic resistance in bacteria | Q39930477 | ||
Minimum inhibitory (MIC) and minimum microbicidal concentration (MMC) of polihexanide and triclosan against antibiotic sensitive and resistant Staphylococcus aureus and Escherichia coli strains | Q40206601 | ||
Notes from the Field: Pan-Resistant New Delhi Metallo-Beta-Lactamase-Producing Klebsiella pneumoniae - Washoe County, Nevada, 2016. | Q40374661 | ||
Interaction of the antibiotics clindamycin and lincomycin with Escherichia coli 23S ribosomal RNA. | Q40534214 | ||
Glycopeptide Antibiotic To Overcome the Intrinsic Resistance of Gram-Negative Bacteria. | Q40541296 | ||
Mode of Action of Quindoxin and Substituted Quinoxaline-di- N -Oxides on Escherichia coli | Q40618501 | ||
The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America | Q41445493 | ||
Evolutionary origins of multidrug and drug-specific efflux pumps in bacteria | Q41722855 | ||
A ten year analysis of multi-drug resistant blood stream infections caused by Escherichia coli & Klebsiella pneumoniae in a tertiary care hospital | Q42258723 | ||
Antimicrobial resistance in generic Escherichia coli isolates from wild small mammals living in swine farm, residential, landfill, and natural environments in southern Ontario, Canada | Q42582937 | ||
Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. | Q42637997 | ||
Secular trend and risk factors for antimicrobial resistance in Escherichia coli isolates in Switzerland 1997-2007. | Q43219801 | ||
Correlation between upstream human activities and riverine antibiotic resistance genes | Q43350186 | ||
Commensal Escherichia coli strains in Guiana reveal a high genetic diversity with host-dependant population structure | Q43502071 | ||
MICs of ciprofloxacin and trimethoprim for Escherichia coli: influence of pH, inoculum size and various body fluids | Q43527362 | ||
Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis | Q44116286 | ||
Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates | Q46341336 | ||
Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain | Q46515054 | ||
Effect of human vicinity on antimicrobial resistance and integrons in animal faecal Escherichia coli | Q46634422 | ||
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
Minimum inhibitory concentration determinations for various antimicrobial agents against 1570 bacterial isolates from turkey poults. | Q50121733 | ||
Antibiotic combination therapy can select for broad-spectrum multidrug resistance in Pseudomonas aeruginosa. | Q50909407 | ||
Detection of Escherichia coli O157:H7 by multiplex PCR and their characterization by plasmid profiling, antimicrobial resistance, RAPD and PFGE analyses. | Q54004591 | ||
Antibiotic resistance of Escherichia coli O157:H7 and O157:NM isolated from animals, food, and humans. | Q54115402 | ||
Clonal relationships among high-level penicillin-resistant Streptococcus pneumoniae in the United States. | Q54118620 | ||
Efflux pumps and drug resistance in gram-negative bacteria. | Q54189845 | ||
cysB and cysE mutants of Escherichia coli K12 show increased resistance to novobiocin. | Q54291265 | ||
Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics. | Q54358881 | ||
Bacterial resistance to streptothricins. | Q54462127 | ||
Correlation between apramycin and gentamicin use in pigs and an increasing reservoir of gentamicin-resistant Escherichia coli. | Q54465068 | ||
Meeting the challenge of antibiotic resistance | Q56828330 | ||
P433 | issue | 4 | |
P921 | main subject | genomics | Q222046 |
Escherichia coli | Q25419 | ||
P304 | page(s) | e000108 | |
P577 | publication date | 2017-04-06 | |
P1433 | published in | Microbial genomics | Q27726981 |
P1476 | title | A population genomics approach to exploiting the accessory 'resistome' of Escherichia coli | |
P478 | volume | 3 |
Q47214307 | Coupling next-generation sequencing to dominant positive screens for finding antibiotic cellular targets and resistance mechanisms in Escherichia coli |
Q64062425 | Effects of Dairy Manure-Based Amendments and Soil Texture on Lettuce- and Radish-Associated Microbiota and Resistomes |
Q90003240 | Persistent metagenomic signatures of early-life hospitalization and antibiotic treatment in the infant gut microbiota and resistome |
Q52609079 | Postgenomics Characterization of an Essential Genetic Determinant of Mammary Pathogenic Escherichia coli. |
Q58780723 | Variant O89 O-Antigen of Is Associated With Group 1 Capsule Loci and Multidrug Resistance |
Search more.